The pharmaceutical giant plans to present the trial data at an upcoming medical conference and submit it to the Food and Drug Administration mid-year. Read this story
The pharmaceutical giant plans to present the trial data at an upcoming medical conference and submit it to the Food and Drug Administration mid-year. Read this story
More from CNBC | Business Biotechnology Biotech and Pharmaceuticals Pharmaceuticals Health care industry Breaking news Eli Lilly and Co Science United States Novo Nordisk A S business news cnbc Articles US: News Companies Business News Health & Science source:tagname:CNBC US Source